Douglass Winthrop Advisors LLC, an SEC-registered investment advisor managing $6.3 billion in assets for individuals, families, trusts and endowments, today announced that Keith Ardizzone has joined the firm as senior managing director on its wealth management team. Ardizzone is based in New York. https://mma.prnewswire.com/media/2749337/Douglass_Winthrop_Advisors_Logo.jpg Before joining Douglass Winthrop, Ardizzone was a senior managing director for […]

PLI and Stanford Law School Announce New Series Hosted by Alex Su CLE-accredited Under Review with Alex Su videos feature conversations with practitioners, changemakers, and researchers on the latest in the law GlobeNewswire August 13, 2025 NEW YORK and STANFORD, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) — Legal professionals today need to keep pace with

— Malaria kills more than 600,000 people each year. — Spatial repellents are easy to use, low-cost, long-lastingtools that release an active ingredient which repels mosquitoes from a room, ultimately lessening the transmission of disease. — This is one of the first new categories of vector control tools to receive a policy recommendation from the

(NasdaqGM:RXST), NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. (“RxSight” or the “Company”)(NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines – RXST GlobeNewswire August 13, 2025 NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. (“RxSight” or the “Company”)(NASDAQ: RXST).

(NASDAQ:NEOG), NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Neogen and certain of its officers and/or directors have engaged

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation – NEOG GlobeNewswire August 13, 2025 NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at

(NASDAQ:CAPR), NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Capricor and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Capricor Therapeutics, Inc. – CAPR GlobeNewswire August 13, 2025 NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR). Such investors are advised to contact Danielle

(NYSE:XIFR), NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against XPLR Infrastructure, LP (“XPLR” or the “Company”) (NYSE: XIFR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to